Stay updated on Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial

Sign up to get notified when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The two screenshots show only minor formatting and layout adjustments; core study details, objectives, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T21:00:00.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    31 days ago
    Change Detected
    Summary
    Major update: version bumped to v3.2.0 and an important government operating status notice added; previous version v3.1.0 deleted.
    Difference
    4%
    Check dated 2025-10-06T05:21:24.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:19.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-14T19:01:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T14:49:20.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility and location information related to Fabry disease and agalsidase alfa, while previous location terms and drug information have been removed.
    Difference
    2%
    Check dated 2025-08-31T11:44:40.000Z thumbnail image

Stay in the know with updates to Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Replagal Dosing in Fabry Disease: Cardiac Function Clinical Trial page.